raclopride and Brain-Ischemia

raclopride has been researched along with Brain-Ischemia* in 2 studies

Other Studies

2 other study(ies) available for raclopride and Brain-Ischemia

ArticleYear
In vivo imaging of dopaminergic neurotransmission after transient focal ischemia in rats.
    Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism, 2013, Volume: 33, Issue:2

    The precise biologic mechanisms involved in functional recovery processes in response to stroke such as dopaminergic neurotransmission are still largely unknown. For this purpose, we performed in parallel in vivo magnetic resonance imaging and positron emission tomography (PET) with [(18)F]fluorodeoxyglucose ([(18)F]FDG) and [(11)C]raclopride at 1, 3, 7, 14, 21, and 28 days after middle cerebral artery occlusion in rats. In the ischemic territory, PET [(18)F]FDG showed a initial decrease in cerebral metabolism followed by a time-dependent recovery to quasi-normal values at day 14 after ischemia. The PET with [(11)C]raclopride, a ligand for dopamine D(2) receptor, showed a sustained binding during the first week after ischemia that declined dramatically from day 14 to day 28. Interestingly, a slight increase in [(11)C]raclopride binding was observed at days 1 to 3 followed by the uppermost binding at day 7 in the contralateral territory. Likewise, in vitro autoradiography using [(3)H]raclopride confirmed these in vivo results. Finally, the neurologic test showed major neurologic impairment at day 1 followed by a recovery of the cerebral function at day 28 after cerebral ischemia. Taken together, these results might suggest that dopamine D(2) receptor changes in the contralateral hemisphere could have a key role in functional recovery after cerebral ischemia.

    Topics: Animals; Brain Ischemia; Dopamine Antagonists; Dopaminergic Neurons; Fluorodeoxyglucose F18; Infarction, Middle Cerebral Artery; Male; Positron-Emission Tomography; Raclopride; Radiography; Radiopharmaceuticals; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D2; Stroke; Synaptic Transmission; Time Factors

2013
ADHD: increased dopamine receptor availability linked to attention deficit and low neonatal cerebral blood flow.
    Developmental medicine and child neurology, 2004, Volume: 46, Issue:3

    Attention-deficit-hyperactivity disorder (ADHD), while largely thought to be a genetic disorder, has environmental factors that appear to contribute significantly to the aetiopathogenesis of the disorder. One such factor is pretern birth with vulnerable cerebrovascular homeostasis. We hypothesised that cerebral ischaemia at birth could contribute to persistent deficient dopaminergic neurotransmission, which is thought to be the pathophysiological basis of the disorder. We examined dopamine D(2/3) receptor binding with positron emission tomography (PET) using [11C] raclopride as a tracer, and continuous reaction times (RT) with a computerized test of variables (TOVA) in six adolescents (12-14 years of age, one female) who had been examined with cerebral blood flow (CBF) measurements at preterm birth and had a subsequent history of attention deficit. We found that high dopamine receptor availability ('empty receptors') was linked with increased RT and RT variability, supporting the concept of a dopaminergic role in symptomatology. High dopamine receptor availability was predicted by low neonatal CBF, supporting the hypothesis of cerebral ischaemia as a contributing factor in infants susceptible to ADHD.

    Topics: Adolescent; Attention; Attention Deficit Disorder with Hyperactivity; Brain; Brain Ischemia; Carbon Radioisotopes; Child; Child, Preschool; Corpus Striatum; Female; Follow-Up Studies; Homeostasis; Humans; Infant, Newborn; Infant, Premature, Diseases; Male; Raclopride; Reaction Time; Receptors, Dopamine; Receptors, Dopamine D2; Receptors, Dopamine D3; Risk Factors; Tomography, Emission-Computed

2004